Global Neurodiagnostics Market By Product (Diagnostic and Imaging Systems, Clinical Testing instruments, Reagents & Consumables), By Indication (Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders), By End-Use (Hospitals, Specialty Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Research Laboratories & Institutes), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

Published date: Nov 2021
Report ID: 73706
Number of Pages: 383
Format:

- 1.Neurodiagnostics Market Introduction
  - 1.1.Definition
  - 1.2.Taxonomy
  - 1.3.Research Scope
- 2.Executive Summary
  - 2.1.Key Findings by Major Segments
  - 2.2.Top strategies by Major Players
- 3.Global Neurodiagnostics Market Overview
  - 3.1.Neurodiagnostics Market Dynamics
    3.1.1.Drivers
    3.1.2.Opportunities
    3.1.3.Restraints
    3.1.4.Challenges
  - 3.2.COVID-19 Impact Analysis
  - 3.3.COVID-19 Impact Analysis in Global Neurodiagnostics Market
  - 3.4.PESTLE Analysis
  - 3.5.Opportunity Map Analysis
  - 3.6.PORTER'S Five Forces Analysis
  - 3.7.Market Competition Scenario Analysis
  - 3.8.Product Life Cycle Analysis
  - 3.9.Opportunity Orbits
  - 3.10.Manufacturer Intensity Map
  - 3.11.Major Companies sales by Value & Volume
- 4.Global Neurodiagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Product Type, 2015-2031
  - 4.1.Global Neurodiagnostics Market Analysis by Product Type: Introduction
  - 4.2.Market Size and Forecast by Region
  - 4.3.Diagnostic and Imaging Systems
    4.3.1.EEG (Electroencephalogram) Systems
    4.3.2.EMG (Electromyography) Products
    4.3.3.MRI Systems
    4.3.4.CT (Computed Tomography) Scanners
    4.3.5.Others
  - 4.4.Clinical Testing instruments
    4.4.1.PCR
    4.4.2.Next-Generation Sequencing
    4.4.3.Sanger Sequencing
    4.4.4.Other Clinical Diagnostic Products
  - 4.5.Reagents & Consumables
    4.5.1.Solvents
    4.5.2.Enzymes, Protein & Peptides
    4.5.3.Probes
    4.5.4.Buffers
    4.5.5.Other Reagents
- 5.Global Neurodiagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Indication, 2015-2031
  - 5.1.Global Neurodiagnostics Market Analysis by Indication: Introduction
  - 5.2.Market Size and Forecast by Region
  - 5.3.Epilepsy
  - 5.4.Stroke
  - 5.5.Headache Disorders
  - 5.6.Other Indications
- 6.Global Neurodiagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by End-User, 2015-2031
  - 6.1.Global Neurodiagnostics Market Analysis by End-User: Introduction
  - 6.2.Market Size and Forecast by Region
  - 6.3.Hospitals
  - 6.4.Specialty Clinics
  - 6.5.Diagnostic Laboratories
  - 6.6.Ambulatory Surgical Centers
  - 6.7.Research Laboratories & Institutes
- 7.Global Neurodiagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2015-2031
  - 7.1.North America
    7.1.1.North America Neurodiagnostics Market: Regional Trend Analysis
    7.1.1.1.U.S.
    7.1.1.2.Canada
    7.1.1.3.Mexico
  - 7.2.1.Europe
    7.2.1.Europe Neurodiagnostics Market: Regional Trend Analysis
    7.2.1.1.U.K.
    7.2.1.2.Germany
    7.2.1.3.France
    7.2.1.4.Spain
    7.2.1.5.Italy
    7.2.1.6.Russia
    7.2.1.7.Rest of Europe
  - 7.3.Asia-Pacific
    7.3.1.Asia-Pacific Neurodiagnostics Market: Regional Trend Analysis
    7.3.1.1.China
    7.3.1.2.Japan
    7.3.1.3.South Korea
    7.3.1.4.India
    7.3.1.5.ASEAN
    7.3.1.6.Rest of Asia-Pacific
  - 7.4.Latin America
    7.4.1.Latin America Neurodiagnostics Market: Regional Trend Analysis
    7.4.1.1.Brazil
    7.4.1.2.Argentina
    7.4.1.3.Rest of Latin America
  - 7.5.Middle East and Africa
    7.5.1.Middle East and Africa Neurodiagnostics Market: Regional Trend Analysis
    7.5.1.1.GCC
    7.5.1.2.Israel
    7.5.1.3.South Africa
    7.5.1.4.Rest of MEA
- 8.Global Neurodiagnostics Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 8.1.Market Share Analysis
  - 8.2.Company Profiles
  - 8.3.GE Healthcare
    8.3.1.Company Overview
    8.3.2.Financial Highlights
    8.3.3.Product Portfolio
    8.3.4.SWOT Analysis
    8.3.5.Key Strategies and Developments
  - 8.4.Siemens Healthineers AG
    8.4.1.Company Overview
    8.4.2.Financial Highlights
    8.4.3.Product Portfolio
    8.4.4.SWOT Analysis
    8.4.5.Key Strategies and Developments
  - 8.5.Philips Healthcare
    8.5.1.Company Overview
    8.5.2.Financial Highlights
    8.5.3.Product Portfolio
    8.5.4.SWOT Analysis
    8.5.5.Key Strategies and Developments
  - 8.6.Hitachi Ltd.
    8.6.1.Company Overview
    8.6.2.Financial Highlights
    8.6.3.Product Portfolio
    8.6.4.SWOT Analysis
    8.6.5.Key Strategies and Developments
  - 8.7.Canon Inc.
    8.7.1.Company Overview
    8.7.2.Financial Highlights
    8.7.3.Product Portfolio
    8.7.4.SWOT Analysis
    8.7.5.Key Strategies and Developments
  - 8.8.Lifelines Neuro Company LLC
    8.8.1.Company Overview
    8.8.2.Financial Highlights
    8.8.3.Product Portfolio
    8.8.4.SWOT Analysis
    8.8.5.Key Strategies and Developments
  - 8.9.Natus Medical Incorporated
    8.9.1.Company Overview
    8.9.2.Financial Highlights
    8.9.3.Product Portfolio
    8.9.4.SWOT Analysis
    8.9.5.Key Strategies and Developments
  - 8.10.F. Hoffmann-La Roche AG
    8.10.1.Company Overview
    8.10.2.Financial Highlights
    8.10.3.Product Portfolio
    8.10.4.SWOT Analysis
    8.10.5.Key Strategies and Developments
  - 8.11.FUJIFILM Holdings Corporation
    8.11.1.Company Overview
    8.11.2.Financial Highlights
    8.11.3.Product Portfolio
    8.11.4.SWOT Analysis
    8.11.5.Key Strategies and Developments
  - 8.12.Mitsar Co. Ltd.
    8.12.1.Company Overview
    8.12.2.Financial Highlights
    8.12.3.Product Portfolio
    8.12.4.SWOT Analysis
    8.12.5.Key Strategies and Developments
  - 8.13.Advanced Brain Monitoring Inc.
    8.13.1.Company Overview
    8.13.2.Financial Highlights
    8.13.3.Product Portfolio
    8.13.4.SWOT Analysis
    8.13.5.Key Strategies and Developments
  - 8.14.Thermo Fisher Scientific Inc.
    8.14.1.Company Overview
    8.14.2.Financial Highlights
    8.14.3.Product Portfolio
    8.14.4.SWOT Analysis
    8.14.5.Key Strategies and Developments
  - 8.15.Bio-Rad Laboratories Inc.
    8.15.1.Company Overview
    8.15.2.Financial Highlights
    8.15.3.Product Portfolio
    8.15.4.SWOT Analysis
    8.15.5.Key Strategies and Developments
  - 8.16.QIAGEN N.V.
    8.16.1.Company Overview
    8.16.2.Financial Highlights
    8.16.3.Product Portfolio
    8.16.4.SWOT Analysis
    8.16.5.Key Strategies and Developments
  - 8.17.Nihon Kohden Corporation
    8.17.1.Company Overview
    8.17.2.Financial Highlights
    8.17.3.Product Portfolio
    8.17.4.SWOT Analysis
    8.17.5.Key Strategies and Developments
  - 8.18.ANT Neuro b.v.
    8.18.1.Company Overview
    8.18.2.Financial Highlights
    8.18.3.Product Portfolio
    8.18.4.SWOT Analysis
    8.18.5.Key Strategies and Developments
  - 8.19.Fonar Corporation
    8.19.1.Company Overview
    8.19.2.Financial Highlights
    8.19.3.Product Portfolio
    8.19.4.SWOT Analysis
    8.19.5.Key Strategies and Developments
  - 8.20.Fujirebio Diagnostics Inc.
    8.20.1.Company Overview
    8.20.2.Financial Highlights
    8.20.3.Product Portfolio
    8.20.4.SWOT Analysis
    8.20.5.Key Strategies and Developments
  - 8.21.DRG Instruments GmbH
    8.21.1.Company Overview
    8.21.2.Financial Highlights
    8.21.3.Product Portfolio
    8.21.4.SWOT Analysis
    8.21.5.Key Strategies and Developments
  - 8.22.Tecan Trading AG
    8.22.1.Company Overview
    8.22.2.Financial Highlights
    8.22.3.Product Portfolio
    8.22.4.SWOT Analysis
    8.22.5.Key Strategies and Developments
  - 8.23.Motion Lab Systems Inc.
    8.23.1.Company Overview
    8.23.2.Financial Highlights
    8.23.3.Product Portfolio
    8.23.4.SWOT Analysis
    8.23.5.Key Strategies and Developments
  - 8.24.Rigaku Corporation
    8.24.1.Company Overview
    8.24.2.Financial Highlights
    8.24.3.Product Portfolio
    8.24.4.SWOT Analysis
    8.24.5.Key Strategies and Developments
  - 8.25.Neusoft Medical Systems Co. Ltd.
    8.25.1.Company Overview
    8.25.2.Financial Highlights
    8.25.3.Product Portfolio
    8.25.4.SWOT Analysis
    8.25.5.Key Strategies and Developments
  - 8.26.ELMIKO MEDICAL Sp. Z o.o.
    8.26.1.Company Overview
    8.26.2.Financial Highlights
    8.26.3.Product Portfolio
    8.26.4.SWOT Analysis
    8.26.5.Key Strategies and Developments
  - 8.27.Ridge Diagnostics Inc.
    8.27.1.Company Overview
    8.27.2.Financial Highlights
    8.27.3.Product Portfolio
    8.27.4.SWOT Analysis
    8.27.5.Key Strategies and Developments
- 9.Assumptions and Acronyms
- 10.Research Methodology
- 11.Contact
- GE Healthcare
- Siemens Healthineers AG
- Philips Healthcare
- Hitachi Ltd. Company Profile
- Canon Inc.
- Lifelines Neuro Company LLC
- Natus Medical Incorporated
- F. Hoffmann-La Roche AG
- FUJIFILM Holdings Corporation Company Profile
- Mitsar Co. Ltd.
- Advanced Brain Monitoring Inc.
- Thermo Fisher Scientific Company Profile
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Nihon Kohden Corporation
- ANT Neuro b.v.
- Fonar Corporation
- Fujirebio Diagnostics Inc.
- DRG Instruments GmbH
- Tecan Trading AG
- Motion Lab Systems Inc.
- Rigaku Corporation
- Neusoft Medical Systems Co. Ltd.
- ELMIKO MEDICAL Sp. Z o.o.
- Ridge Diagnostics Inc.
- others
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $5,999 $2,999 USD / per unit save 50%	Multi User $7,999 $3,499 USD / per unit save 55%	Corporate User $12,999 $4,499 USD / per unit save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 2,999)	Buy Now ($ 3,499)	Buy Now ($ 4,499)